TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Web-Based CBT for Rape Victims
Brief Summary: Rape is unfortunately a common experience among women, affecting between 13 and 20%. In addition, up to 50% of all rape victims experience significant and persistent psychological distress. While cognitive-behavioral interventions have been found to be successful at alleviating distress among victims; the majority do not seek out these services, often because of feelings of stigma and self-blame. One potential method for circumventing these barriers is through online administered treatment. Thus, the current project is designed to conduct an initial evaluation of a 12 to 16-week, therapist-facilitated, multi-media, cognitive-behavioral, online intervention tailored specifically for rape victims. The effectiveness of this program at ameliorating distress among college women who have experienced rape and have current posttraumatic stress disorder (PTSD) was evaluated. Reductions in psychological distress was the primary outcome and was assessed at post-intervention and at three and six month follow-up periods. The effectiveness of the intervention was compared to a psycho-educational website.


Options:
A: Arm Label: Online intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Online intervention | Arm Label: Psycho-educational website; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psycho-educational website | Intervention Type: BEHAVIORAL; Name: Online intervention; Assigned to Arm(s): Online intervention | Intervention Type: BEHAVIORAL; Name: Psycho-educational website; Assigned to Arm(s): Psycho-educational website
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated psychotherapy for PTSD and substance use | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 12-step based supportive therapy | Intervention Type: BEHAVIORAL; Name: Integrated psychotherapy for PTSD and substance use; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: 12-step based supportive therapy; Assigned to Arm(s): 2
C: Arm Label: PE-HBT; Type: EXPERIMENTAL; Interventions: Behavioral: PE | Arm Label: PE-SD; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: PE | Intervention Type: BEHAVIORAL; Name: PE; Assigned to Arm(s): PE-HBT, PE-SD
D: Arm Label: High Interference Control Condition; Type: EXPERIMENTAL; Interventions: Other: Computerized Cognitive Training - active | Arm Label: Low Interference Control Condition; Type: ACTIVE_COMPARATOR; Interventions: Other: Computerized cognitive training - sham | Intervention Type: OTHER; Name: Computerized Cognitive Training - active; Assigned to Arm(s): High Interference Control Condition | Intervention Type: OTHER; Name: Computerized cognitive training - sham; Assigned to Arm(s): Low Interference Control Condition

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Recovery of Physical Functioning, Activity Level, and Quality of Life After Hip Fracture in the Fragile Elderly
Brief Summary: The survivors after hip fracture often report severe pain and loss of physical functioning. The poor outcomes cause negative impact on the person's physical functioning and quality of life and put a financial burden on society. It is important to continue and progress the functional training that already started at the hospital, while the patients are transferred to short-term stays in a nursing home before they are returning to home. The aim presently is to examine the effects of a functional training program by a RCT design, initiated by the physiotherapist and performed by the nurses, on physical functioning while the patients are at short term stays in primary health care.


Options:
A: Arm Label: Enhanced Physical Activity; Type: EXPERIMENTAL; Interventions: Other: Enhanced Physical Activity, Other: Usual Care | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care, Other: Social Interaction | Intervention Type: OTHER; Name: Enhanced Physical Activity; Assigned to Arm(s): Enhanced Physical Activity | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Enhanced Physical Activity, Usual Care | Intervention Type: OTHER; Name: Social Interaction; Assigned to Arm(s): Usual Care
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Fall risk assessment, Other: Tailored intervention | Arm Label: Control; Type: OTHER; Interventions: Other: Fall risk assessment | Intervention Type: OTHER; Name: Fall risk assessment; Assigned to Arm(s): Control, Intervention | Intervention Type: OTHER; Name: Tailored intervention; Assigned to Arm(s): Intervention
C: Arm Label: Functional training group; Type: EXPERIMENTAL; Interventions: Other: Functional training program | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Functional training program; Assigned to Arm(s): Functional training group
D: Arm Label: Person-centered Care; Type: EXPERIMENTAL; Interventions: Other: Person-centered Care, Other: Optimised Treatment | Arm Label: Optimised Treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: Optimised Treatment | Intervention Type: OTHER; Name: Person-centered Care; Assigned to Arm(s): Person-centered Care | Intervention Type: OTHER; Name: Optimised Treatment; Assigned to Arm(s): Optimised Treatment, Person-centered Care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Recovery of Physical Functioning, Activity Level, and Quality of Life After Hip Fracture in the Fragile Elderly
Brief Summary: The survivors after hip fracture often report severe pain and loss of physical functioning. The poor outcomes cause negative impact on the person's physical functioning and quality of life and put a financial burden on society. It is important to continue and progress the functional training that already started at the hospital, while the patients are transferred to short-term stays in a nursing home before they are returning to home. The aim presently is to examine the effects of a functional training program by a RCT design, initiated by the physiotherapist and performed by the nurses, on physical functioning while the patients are at short term stays in primary health care.


Options:
A: Arm Label: Functional training group; Type: EXPERIMENTAL; Interventions: Other: Functional training program | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Functional training program; Assigned to Arm(s): Functional training group
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise Plus Program | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise Plus Program; Assigned to Arm(s): 1
C: Intervention Type: DRUG; Name: MK0677; Assigned to Arm(s): N/A
D: Arm Label: Home-based physical exercise; Type: EXPERIMENTAL; Interventions: Other: Home-based physical exercise intervention | Arm Label: Control Group Usual Care; Type: OTHER; Interventions: Other: Control Group Usual Care | Intervention Type: OTHER; Name: Home-based physical exercise intervention; Assigned to Arm(s): Home-based physical exercise | Intervention Type: OTHER; Name: Control Group Usual Care; Assigned to Arm(s): Control Group Usual Care

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Recovery of Physical Functioning, Activity Level, and Quality of Life After Hip Fracture in the Fragile Elderly
Brief Summary: The survivors after hip fracture often report severe pain and loss of physical functioning. The poor outcomes cause negative impact on the person's physical functioning and quality of life and put a financial burden on society. It is important to continue and progress the functional training that already started at the hospital, while the patients are transferred to short-term stays in a nursing home before they are returning to home. The aim presently is to examine the effects of a functional training program by a RCT design, initiated by the physiotherapist and performed by the nurses, on physical functioning while the patients are at short term stays in primary health care.


Options:
A: Arm Label: Enhanced collaboration; Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced collaboration to promote patient participation | Arm Label: Usual Care Treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care treatment | Intervention Type: OTHER; Name: Enhanced collaboration to promote patient participation; Assigned to Arm(s): Enhanced collaboration | Intervention Type: OTHER; Name: Usual Care treatment; Assigned to Arm(s): Usual Care Treatment
B: Arm Label: Interdisciplinary group; Type: EXPERIMENTAL; Interventions: Other: Diabetes interdisciplinary program | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Diabetes interdisciplinary program; Assigned to Arm(s): Interdisciplinary group
C: Arm Label: Functional training group; Type: EXPERIMENTAL; Interventions: Other: Functional training program | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Functional training program; Assigned to Arm(s): Functional training group
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Other: Interdisciplinary intervention program | Intervention Type: OTHER; Name: Interdisciplinary intervention program; Assigned to Arm(s): Experimental group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Multi-center, Randomized, 2-arm, Open-label Study of Intermittent Oral Dosing of ASP1517 in Erythropoiesis Stimulating Agent-naive Hemodialysis Chronic Kidney Disease Patients With Anemia
Brief Summary: The objective of this study is to evaluate the safety and efficacy of ASP1517 in ESA-naive hemodialysis chronic kidney disease patients with anemia.


Options:
A: Arm Label: Daprodustat; Type: EXPERIMENTAL; Interventions: Drug: Daprodustat small, Drug: Daprodustat large, Drug: Darbepoetin alfa placebo | Arm Label: Darbepoetin alfa; Type: ACTIVE_COMPARATOR; Interventions: Drug: Daprodustat small placebo, Drug: Daprodustat large placebo, Drug: Darbepoetin alfa | Intervention Type: DRUG; Name: Daprodustat small; Assigned to Arm(s): Daprodustat | Intervention Type: DRUG; Name: Daprodustat small placebo; Assigned to Arm(s): Darbepoetin alfa | Intervention Type: DRUG; Name: Daprodustat large; Assigned to Arm(s): Daprodustat | Intervention Type: DRUG; Name: Daprodustat large placebo; Assigned to Arm(s): Darbepoetin alfa | Intervention Type: DRUG; Name: Darbepoetin alfa; Assigned to Arm(s): Darbepoetin alfa | Intervention Type: DRUG; Name: Darbepoetin alfa placebo; Assigned to Arm(s): Daprodustat
B: Arm Label: ASP1517 Low dose Group; Type: EXPERIMENTAL; Interventions: Drug: roxadustat | Arm Label: ASP1517 High dose Group; Type: EXPERIMENTAL; Interventions: Drug: roxadustat | Intervention Type: DRUG; Name: roxadustat; Assigned to Arm(s): ASP1517 High dose Group, ASP1517 Low dose Group
C: Arm Label: Vadadustat 600 mg; Type: EXPERIMENTAL; Interventions: Drug: Vadadustat | Arm Label: Vadadustat 750 mg; Type: EXPERIMENTAL; Interventions: Drug: Vadadustat | Arm Label: Vadadustat 900 mg; Type: EXPERIMENTAL; Interventions: Drug: Vadadustat | Arm Label: Erythropoiesis-stimulating agent; Type: OTHER; Interventions: Drug: Darbepoetin alfa, Drug: Epoetin alfa | Intervention Type: DRUG; Name: Vadadustat; Assigned to Arm(s): Vadadustat 600 mg, Vadadustat 750 mg, Vadadustat 900 mg | Intervention Type: DRUG; Name: Darbepoetin alfa; Assigned to Arm(s): Erythropoiesis-stimulating agent | Intervention Type: DRUG; Name: Epoetin alfa; Assigned to Arm(s): Erythropoiesis-stimulating agent
D: Arm Label: AKB-6548; Type: EXPERIMENTAL; Interventions: Drug: AKB-6548 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: AKB-6548; Assigned to Arm(s): AKB-6548 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prophylactic Negative Pressure Dressings for Closed Laparotomy Wounds - A Randomised, Controlled, Open Label Trial
Brief Summary: Laparotomy wounds are associated with high rates of surgical site infections (SSI). The effect of prophylactic negative pressure dressing of closed incisional wounds on SSI rates is inconclusive.


Options:
A: Arm Label: Negative pressure dressing; Type: EXPERIMENTAL; Interventions: Device: Negative pressure dressing | Arm Label: Standard dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard wound dressing | Intervention Type: DEVICE; Name: Negative pressure dressing; Assigned to Arm(s): Negative pressure dressing | Intervention Type: DEVICE; Name: Standard wound dressing; Assigned to Arm(s): Standard dressing
B: Arm Label: Vacuum-assisted closure (VAC); Type: EXPERIMENTAL; Interventions: Device: Vacuum-assisted closure | Arm Label: Standard sterile dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard sterile dressing | Intervention Type: DEVICE; Name: Vacuum-assisted closure; Assigned to Arm(s): Vacuum-assisted closure (VAC) | Intervention Type: DEVICE; Name: Standard sterile dressing; Assigned to Arm(s): Standard sterile dressing
C: Arm Label: Dry Dressing; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: V.A.C. by K.C.I. | Intervention Type: DEVICE; Name: V.A.C. by K.C.I.; Assigned to Arm(s): Negative Pressure Wound Therapy
D: Arm Label: Breast Recon with acellular dermal matrix (ADM) on NPWT; Type: EXPERIMENTAL; Interventions: Device: Renasys*GO Negative Pressure Wound Therapy System | Arm Label: Lipoabdominoplasty on NPWT; Type: EXPERIMENTAL; Interventions: Device: Renasys*GO Negative Pressure Wound Therapy System | Arm Label: Abdominoplasty on NPWT; Type: EXPERIMENTAL; Interventions: Device: Renasys*GO Negative Pressure Wound Therapy System | Arm Label: Ventral Hernia Repair (VHR) on NPWT; Type: EXPERIMENTAL; Interventions: Device: Renasys*GO Negative Pressure Wound Therapy System | Arm Label: Panniculectomy on NPWT; Type: EXPERIMENTAL; Interventions: Device: Renasys*GO Negative Pressure Wound Therapy System | Arm Label: Breast Recon with ADM on Jackson-Pratt (JP) Drains; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Abdominoplasty on JP Drains; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Lipoabdominoplasty on JP Drains; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Ventral Hernia Repair (VHR) on JP Drains; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Panniculectomy on JP Drains; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Renasys*GO Negative Pressure Wound Therapy System; Assigned to Arm(s): Abdominoplasty on NPWT, Breast Recon with acellular dermal matrix (ADM) on NPWT, Lipoabdominoplasty on NPWT, Panniculectomy on NPWT, Ventral Hernia Repair (VHR) on NPWT

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prophylactic Negative Pressure Dressings for Closed Laparotomy Wounds - A Randomised, Controlled, Open Label Trial
Brief Summary: Laparotomy wounds are associated with high rates of surgical site infections (SSI). The effect of prophylactic negative pressure dressing of closed incisional wounds on SSI rates is inconclusive.


Options:
A: Arm Label: High Risk - Prevena Care; Type: EXPERIMENTAL; Interventions: Device: Prevena Care | Arm Label: High Risk - Dry Gauze Dressing Care; Type: ACTIVE_COMPARATOR; Interventions: Device: Dry gauze dressing care | Arm Label: Low Risk - Dry Gauze Dressing Care; Type: ACTIVE_COMPARATOR; Interventions: Device: Dry gauze dressing care | Intervention Type: DEVICE; Name: Prevena Care; Assigned to Arm(s): High Risk - Prevena Care | Intervention Type: DEVICE; Name: Dry gauze dressing care; Assigned to Arm(s): High Risk - Dry Gauze Dressing Care, Low Risk - Dry Gauze Dressing Care
B: Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: Negative pressure wound therapy | Arm Label: Standard dressing; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Negative pressure wound therapy; Assigned to Arm(s): Negative Pressure Wound Therapy
C: Arm Label: Prevena device (Group A); Type: EXPERIMENTAL; Interventions: Device: Prevena device (Group A) | Arm Label: Conventional dressing (Group B); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Prevena device (Group A); Assigned to Arm(s): Prevena device (Group A)
D: Arm Label: Negative pressure dressing; Type: EXPERIMENTAL; Interventions: Device: Negative pressure dressing | Arm Label: Standard dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard wound dressing | Intervention Type: DEVICE; Name: Negative pressure dressing; Assigned to Arm(s): Negative pressure dressing | Intervention Type: DEVICE; Name: Standard wound dressing; Assigned to Arm(s): Standard dressing

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prophylactic Negative Pressure Dressings for Closed Laparotomy Wounds - A Randomised, Controlled, Open Label Trial
Brief Summary: Laparotomy wounds are associated with high rates of surgical site infections (SSI). The effect of prophylactic negative pressure dressing of closed incisional wounds on SSI rates is inconclusive.


Options:
A: Arm Label: Prevena device (Group A); Type: EXPERIMENTAL; Interventions: Device: Prevena device (Group A) | Arm Label: Conventional dressing (Group B); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Prevena device (Group A); Assigned to Arm(s): Prevena device (Group A)
B: Arm Label: Closed Incision Wound vacuum (Prevena); Type: EXPERIMENTAL; Interventions: Device: Closed incision wound vacuum (Prevena) | Arm Label: Routine Wound Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Closed incision wound vacuum (Prevena); Assigned to Arm(s): Closed Incision Wound vacuum (Prevena)
C: Arm Label: Negative pressure dressing; Type: EXPERIMENTAL; Interventions: Device: Negative pressure dressing | Arm Label: Standard dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard wound dressing | Intervention Type: DEVICE; Name: Negative pressure dressing; Assigned to Arm(s): Negative pressure dressing | Intervention Type: DEVICE; Name: Standard wound dressing; Assigned to Arm(s): Standard dressing
D: Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: Negative pressure wound therapy | Arm Label: Standard dressing; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Negative pressure wound therapy; Assigned to Arm(s): Negative Pressure Wound Therapy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prophylactic Negative Pressure Dressings for Closed Laparotomy Wounds - A Randomised, Controlled, Open Label Trial
Brief Summary: Laparotomy wounds are associated with high rates of surgical site infections (SSI). The effect of prophylactic negative pressure dressing of closed incisional wounds on SSI rates is inconclusive.


Options:
A: Arm Label: Standard Dressing; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Postoperative NPWT dressing; Type: EXPERIMENTAL; Interventions: Device: Postoperative Negative Pressure Wound Therapy KCI NANOVA | Intervention Type: DEVICE; Name: Postoperative Negative Pressure Wound Therapy KCI NANOVA; Assigned to Arm(s): Postoperative NPWT dressing
B: Arm Label: Negative pressure dressing; Type: EXPERIMENTAL; Interventions: Device: Negative pressure dressing | Arm Label: Standard dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard wound dressing | Intervention Type: DEVICE; Name: Negative pressure dressing; Assigned to Arm(s): Negative pressure dressing | Intervention Type: DEVICE; Name: Standard wound dressing; Assigned to Arm(s): Standard dressing
C: Arm Label: Standard wound dressing OPEN; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PICO dressing OPEN; Type: EXPERIMENTAL; Interventions: Device: Negative pressure wound therapy with PICO (Smith & Nephew) | Arm Label: Standard dressing EVAR; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PICO dressing EVAR; Type: EXPERIMENTAL; Interventions: Device: Negative pressure wound therapy with PICO (Smith & Nephew) | Intervention Type: DEVICE; Name: Negative pressure wound therapy with PICO (Smith & Nephew); Assigned to Arm(s): PICO dressing EVAR, PICO dressing OPEN
D: Arm Label: Vacuum-assisted closure (VAC); Type: EXPERIMENTAL; Interventions: Device: Vacuum-assisted closure | Arm Label: Standard sterile dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard sterile dressing | Intervention Type: DEVICE; Name: Vacuum-assisted closure; Assigned to Arm(s): Vacuum-assisted closure (VAC) | Intervention Type: DEVICE; Name: Standard sterile dressing; Assigned to Arm(s): Standard sterile dressing

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Exercise on Physical Function in Older Women With Osteoporosis and a History of Vertebral Fracture: A Randomized Controlled Trial
Brief Summary: The study is a parallel-group single blinded randomized controlled trial, examining the effect of exercise on physical function in older women with osteoporosis and a history of vertebral fracture. The participants will randomly be assigned in a 1:1 ratio to the intervention group and the control group. The intervention will follow newly developed exercise recommendations for people with osteoporosis and vertebral fractures, which states the balance- and strength exercises should be performed at least twice a week. The intervention is a group exercise session circuit program lasting for 12 weeks. The participants will be tested at baseline, and followed up at 3 months and 6 months.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Exercise | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Intervention
B: Arm Label: Spinal orthosis group; Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal orthosis Spinomed | Arm Label: Equipment training group; Type: ACTIVE_COMPARATOR; Interventions: Other: Equipment training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Spinal orthosis Spinomed; Assigned to Arm(s): Spinal orthosis group | Intervention Type: OTHER; Name: Equipment training; Assigned to Arm(s): Equipment training group
C: Arm Label: Physical Activity; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physical Activity | Arm Label: Successful Aging; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Successful Aging | Intervention Type: BEHAVIORAL; Name: Physical Activity; Assigned to Arm(s): Physical Activity | Intervention Type: BEHAVIORAL; Name: Successful Aging; Assigned to Arm(s): Successful Aging
D: Arm Label: Exercise and advise to stay active; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise | Arm Label: Rest and use of flexible lumbar belt; Type: EXPERIMENTAL; Interventions: Other: Restitution | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Exercise and advise to stay active | Intervention Type: OTHER; Name: Restitution; Assigned to Arm(s): Rest and use of flexible lumbar belt

Answer: A